Commercial Scale Up and Financials Report
Overview
Market Opportunity Product Line & Evidence Commercial Scale Up Insurance Reimbursement Financials
Reimbursement Status: International Markets
myomo
my own motion
Germany: Reimbursement for the MyoPro is on a case-by-case basis, with
insurance companies often paying for a six-month trial to demonstrate the
benefit to the patient, followed by full payment for the device in over half of
these trial cases
Several positive rulings by the Social Court stating that Statutory Health
Insurance (SHI) firms such as Barmer must reimburse for the MyoPro
Australia: National Disability Insurance Scheme (NDIS) has now approved
reimbursement for the MyoPro, which should lead to additional sales in the
country
Other Markets: Reimbursement is obtained by working through local O&P
distribution partners on a case-by-case basis (UK, Italy, Denmark)
T<
Die
Techniker
BARMER
ndis
17View entire presentation